Rallybio (RLYB) Stock: Buy, Sell, or Hold?
RLYB - Rallybio Corporation Common Stock
$16.40
0.18 (1.11%)
▲
5d:
-2.24%
30d:
-2.73%
90d:
+0.55%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When RLYB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RLYB shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RLYB shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: RLYB is currently trading at $16.40, which is considered oversold relative to its 30-day fair value range of $16.54 to $17.13.
Technical Outlook: Technically, RLYB is in a strong uptrend. The price is currently testing key support at $16.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $8.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RLYB is in a strong uptrend. The price is currently testing key support at $16.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $8.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.54 -
$17.13
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 50.7% above Wall St target ($8.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.54 -
$17.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.16
Resistance Level
$17.22
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.51
Wall Street Target
$8.00
(-50.7%)
Profit Margin
7051.2%
Share & Embed Analysis
Last updated: October 22, 2026 2:58 PM ET
Data refreshes hourly during market hours. Next update: 3:58 PM
Data refreshes hourly during market hours. Next update: 3:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLYB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 66 BUY |
|
IMUX
Immunic Inc |
STRONG BUY
12 analysts |
$43 | 70 BUY |
